Oladipo Olaleye
Psychiatric/Mental Health · Windsor Mill, MDNPI 1467888529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 36.4% of the total. 2025 is the largest year on record at $206, 9.5 times the $22 reported in 2022. That places this record below the midpoint for psychiatric/mental health clinicians in MD, where the typical reported total is $349.
Across 17 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$134
- Lundbeck LLC$100
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$49
- Johnson & Johnson$28
- Otsuka America Pharmaceutical, Inc.$22
- E.r. Squibb & Sons, L.L.C.$20
- plus $14 from 1 others
What the payments were for
- Food & beverage$367100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $134 |
| Lundbeck LLC | 5 | $100 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $49 |
| Johnson & Johnson | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Alkermes, Inc. | 1 | $14 |
How this compares
$367 in reported general payments places this provider in the 50th percentile of 1,461 psychiatric/mental health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 11 | $4,818 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $3,018 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 135 | $2,844 |
| Aripiprazole | 104 | $2,389 |
| Alprazolam | 563 | $2,068 |
| Clonazepam | 475 | $1,507 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 33 | $1,439 |
| Quetiapine Fumarate | 236 | $1,244 |
| Olanzapine | 76 | $1,015 |
| Gabapentin | 150 | $1,001 |
| Bupropion XlBupropion Hcl | 92 | $849 |
| Doxepin Hcl | 77 | $777 |
| Duloxetine Hcl | 87 | $760 |
| Fluoxetine Hcl | 160 | $667 |
| Escitalopram Oxalate | 262 | $664 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Windsor Mill
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
- Anyinke AtabongRockville$15K
- Zenatsehay GebretsadikColumbia$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.